Blood-thinners Xarelto, Eliquis and Pradaxa marketed to doctors as drug companies splash cash - ABC News
![ESC: Pfizer, BMS' Eliquis tops Xarelto, vitamin K drugs for site-specific bleeding risks in French real-world study | Fierce Pharma ESC: Pfizer, BMS' Eliquis tops Xarelto, vitamin K drugs for site-specific bleeding risks in French real-world study | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1598718319/1588487_Eliquis%205mg%20Box_Bottle.jpg/1588487_Eliquis%205mg%20Box_Bottle.jpg?VersionId=SnFjxOSTzU_XLUf7iFZH8t_h8.el7dSa)
ESC: Pfizer, BMS' Eliquis tops Xarelto, vitamin K drugs for site-specific bleeding risks in French real-world study | Fierce Pharma
![Bayer and Johnson & Johnson Settle Lawsuits Over Xarelto, a Blood Thinner, for $775 Million - The New York Times Bayer and Johnson & Johnson Settle Lawsuits Over Xarelto, a Blood Thinner, for $775 Million - The New York Times](https://static01.nyt.com/images/2019/03/25/science/25BLOODTHINNER/25BLOODTHINNER-videoSixteenByNine3000.jpg?year=2019&h=1687&w=3000&s=f0f4f8af60beadcaf3843a973f9179f70193494ad832620257599453d55ce5b5&k=ZQJBKqZ0VN&tw=1)
Bayer and Johnson & Johnson Settle Lawsuits Over Xarelto, a Blood Thinner, for $775 Million - The New York Times
![Bayer and Johnson & Johnson Settle Lawsuits Over Xarelto, a Blood Thinner, for $775 Million - The New York Times Bayer and Johnson & Johnson Settle Lawsuits Over Xarelto, a Blood Thinner, for $775 Million - The New York Times](https://static01.nyt.com/images/2019/03/25/science/25BLOODTHINNER/25BLOODTHINNER-articleLarge.jpg?quality=75&auto=webp&disable=upscale)